Enterprise Value

567M

Cash

81.3M

Avg Qtr Burn

-27.78M

Short % of Float

6.24%

Insider Ownership

0.17%

Institutional Own.

52.79%

Qtr Updated

12/31/23


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date

Phase 3

Data readout

PRAX-628 Details
Epilepsy, Focal Onset Seizures

Phase 2b

Initiation

Phase 2

Data readout

PRAX-562 Details
Developmental and Epileptic Encephalopathy

Phase 2

Data readout

PRAX-222 Details
Developmental and Epileptic Encephalopathy

Phase 1/2

Data readout

Failed

Discontinued

Failed

Discontinued